» Articles » PMID: 28384650

Association of ARHGAP18 Polymorphisms with Schizophrenia in the Chinese-Han Population

Overview
Journal PLoS One
Date 2017 Apr 7
PMID 28384650
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Numerous developmental genes have been linked to schizophrenia (SZ) by case-control and genome-wide association studies, suggesting that neurodevelopmental disturbances are major pathogenic mechanisms. However, no neurodevelopmental deficit has been definitively linked to SZ occurrence, likely due to disease heterogeneity and the differential effects of various gene variants across ethnicities. Hence, it is critical to examine linkages in specific ethnic populations, such as Han Chinese. The newly identified RhoGAP ARHGAP18 is likely involved in neurodevelopment through regulation of RhoA/C. Here we describe four single nucleotide polymorphisms (SNPs) in ARHGAP18 associated with SZ across a cohort of >2000 cases and controls from the Han population. Two SNPs, rs7758025 and rs9483050, displayed significant differences between case and control groups both in genotype (P = 0.0002 and P = 7.54×10-6) and allelic frequencies (P = 4.36×10-5 and P = 5.98×10-7), respectively. The AG haplotype in rs7758025-rs9385502 was strongly associated with the occurrence of SZ (P = 0.0012, OR = 0.67, 95% CI = 0.48-0.93), an association that still held following a 1000-times random permutation test (P = 0.022). In an independently collected validation cohort, rs9483050 was the SNP most strongly associated with SZ. In addition, the allelic frequencies of rs12197901 remained associated with SZ in the combined cohort (P = 0.021), although not in the validation cohort alone (P = 0.251). Collectively, our data suggest the ARHGAP18 may confer vulnerability to SZ in the Chinese Han population, providing additional evidence for the involvement of neurodevelopmental dysfunction in the pathogenesis of schizophrenia.

Citing Articles

Genomic and Reverse Translational Analysis Discloses a Role for Small GTPase RhoA Signaling in the Pathogenesis of Schizophrenia: Rho-Kinase as a Novel Drug Target.

Tanaka R, Yamada K Int J Mol Sci. 2023; 24(21).

PMID: 37958606 PMC: 10648424. DOI: 10.3390/ijms242115623.


A Mouse Systems Genetics Approach Reveals Common and Uncommon Genetic Modifiers of Hepatic Lysosomal Enzyme Activities and Glycosphingolipids.

Duran A, Priestman D, Heras M, Rebolledo-Jaramillo B, Olguin V, Calderon J Int J Mol Sci. 2023; 24(5).

PMID: 36902345 PMC: 10002577. DOI: 10.3390/ijms24054915.


Inherited L1 Retrotransposon Insertions Associated With Risk for Schizophrenia and Bipolar Disorder.

Reiner B, Doyle G, Weller A, Levinson R, Rao A, Davila Perea E Schizophr Bull Open. 2021; 2(1):sgab031.

PMID: 34901866 PMC: 8650070. DOI: 10.1093/schizbullopen/sgab031.


Regulators of Rho GTPases in the Nervous System: Molecular Implication in Axon Guidance and Neurological Disorders.

Niftullayev S, Lamarche-Vane N Int J Mol Sci. 2019; 20(6).

PMID: 30934641 PMC: 6471118. DOI: 10.3390/ijms20061497.

References
1.
Datta D, Arion D, Corradi J, Lewis D . Altered expression of CDC42 signaling pathway components in cortical layer 3 pyramidal cells in schizophrenia. Biol Psychiatry. 2015; 78(11):775-85. PMC: 4600637. DOI: 10.1016/j.biopsych.2015.03.030. View

2.
Billuart P, Bienvenu T, Ronce N, Portes V, Vinet M, Zemni R . Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation. Nature. 1998; 392(6679):923-6. DOI: 10.1038/31940. View

3.
Loh P, Bhatia G, Gusev A, Finucane H, Bulik-Sullivan B, Pollack S . Contrasting genetic architectures of schizophrenia and other complex diseases using fast variance-components analysis. Nat Genet. 2015; 47(12):1385-92. PMC: 4666835. DOI: 10.1038/ng.3431. View

4.
. Genome-wide association study identifies five new schizophrenia loci. Nat Genet. 2011; 43(10):969-76. PMC: 3303194. DOI: 10.1038/ng.940. View

5.
Zanni G, Saillour Y, Nagara M, Billuart P, Castelnau L, Moraine C . Oligophrenin 1 mutations frequently cause X-linked mental retardation with cerebellar hypoplasia. Neurology. 2005; 65(9):1364-9. DOI: 10.1212/01.wnl.0000182813.94713.ee. View